Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial ; volume:21 ; number:1 ; day:19 ; month:8 ; year:2023 ; pages:1-9 ; date:12.2023
World journal of surgical oncology ; 21, Heft 1 (19.8.2023), 1-9, 12.2023
- Creator
-
Žatecký, Jan
Coufal, Oldřich
Zapletal, Ondřej
Kubala, Otakar
Kepičová, Markéta
Faridová, Adéla
Rauš, Karel
Gatěk, Jiří
Kosáč, Peter
Peteja, Matúš
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-023-03147-x
- URN
-
urn:nbn:de:101:1-2023110414393771455306
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Žatecký, Jan
- Coufal, Oldřich
- Zapletal, Ondřej
- Kubala, Otakar
- Kepičová, Markéta
- Faridová, Adéla
- Rauš, Karel
- Gatěk, Jiří
- Kosáč, Peter
- Peteja, Matúš
- SpringerLink (Online service)
Other Objects (12)
Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study
Targeted Axillary Dissection with 125I Seed Placement Before Neoadjuvant Chemotherapy in a Danish Multicenter Cohort
„Targeted axillary dissection“ bei nodal positivem Mammakarzinom-Patienten nach neoadjuvanter Chemotherapie: eine prospektive, multizentrische Registerstudie
Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy
A Prospective Study of the Efficacy of Endofascial Axillary Dissection to Reduce Axillary Seroma Formation
Left axillary cannulation for acute type A aortic dissection
Breast cancer in older woman: can axillary dissection be omitted?
Postoperative peri-axillary seroma following axillary artery cannulation for surgical treatment of acute type A aortic dissection
Axilla-Staging nach neoadjuvanter Therapie des Mammakarzinoms : technische und klinische Aspekte von Target Lymph Node Biopsy und Targeted Axillary Dissection
Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy
Axillary dissection versus axillary observation for low risk, clinically node-negative invasive breast cancer: a systematic review and meta-analysis
Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study
Targeted Axillary Dissection with 125I Seed Placement Before Neoadjuvant Chemotherapy in a Danish Multicenter Cohort
„Targeted axillary dissection“ bei nodal positivem Mammakarzinom-Patienten nach neoadjuvanter Chemotherapie: eine prospektive, multizentrische Registerstudie
Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy
A Prospective Study of the Efficacy of Endofascial Axillary Dissection to Reduce Axillary Seroma Formation
Left axillary cannulation for acute type A aortic dissection
Breast cancer in older woman: can axillary dissection be omitted?
Postoperative peri-axillary seroma following axillary artery cannulation for surgical treatment of acute type A aortic dissection
Axilla-Staging nach neoadjuvanter Therapie des Mammakarzinoms : technische und klinische Aspekte von Target Lymph Node Biopsy und Targeted Axillary Dissection
Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy
Axillary dissection versus axillary observation for low risk, clinically node-negative invasive breast cancer: a systematic review and meta-analysis
Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study
Targeted Axillary Dissection with 125I Seed Placement Before Neoadjuvant Chemotherapy in a Danish Multicenter Cohort
„Targeted axillary dissection“ bei nodal positivem Mammakarzinom-Patienten nach neoadjuvanter Chemotherapie: eine prospektive, multizentrische Registerstudie
Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy
A Prospective Study of the Efficacy of Endofascial Axillary Dissection to Reduce Axillary Seroma Formation
Left axillary cannulation for acute type A aortic dissection
Breast cancer in older woman: can axillary dissection be omitted?
Postoperative peri-axillary seroma following axillary artery cannulation for surgical treatment of acute type A aortic dissection
Axilla-Staging nach neoadjuvanter Therapie des Mammakarzinoms : technische und klinische Aspekte von Target Lymph Node Biopsy und Targeted Axillary Dissection
Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy